Is a complete BGLC research report available?

No complete published report is available for BioNexus Gene Lab Corp. (BGLC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BioNexus Gene Lab Corp. (BGLC)

NASDAQ: BGLC · USD

$1.05

-0.08 (-7.1%)· Recorded snapshot

Market cap	3.1M
Revenue (ttm)	3.1M
Net income (ttm)	-2.6M
EPS (ttm)	-$1.19
Shares out	2.9M
Volume	3,919
Beta	2.20

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.1M
Net income (ttm): -2.6M
EPS (ttm): -$1.19
Market cap: 3.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALB	Albemarle Corporation	11.4B	198.9x	1.9x	4.1%	+12.8%	+1.9%	Hold
APD	Air Products and Chemicals, Inc.	68.3B	—	5.4x	8.9%	+5.2%	+23.1%	Hold
AVY	Avery Dennison Corporation	13.7B	19.8x	1.5x	15.1%	+3.3%	+1.6%	Hold

Metric	Value
Amount currency	USD
CIK code	0001737523
Company name	BioNexus Gene Lab Corp.
Country	Malaysia
Country code	US
CUSIP number	090628306
Earnings date	2026-11-13
Earnings time	amc
Employees	19
Employees change	-13
Employees growth	-40.63%
Enterprise value	$-118,221
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2017
Industry	Specialty Chemicals
Is primary listing	Yes
Is SPAC	No
ISIN number	US0906283066
Last 10-K release date	2026-04-14
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2025-04-07
Last stock split type	Reverse
Market cap	$3.1M
Market cap category	Nano-Cap
Next earnings date	2026-11-13
Options	No
Price	$1.05
Price currency	USD
Sector	Materials
SIC code	8071
Stock price date	2026-10-28
Symbol	BGLC
Website	https://www.bionexusgenelab.com

Metric

Value

Amount currency

USD

CIK code

0001737523

Company name

BioNexus Gene Lab Corp.

Country

Malaysia

Country code

CUSIP number

090628306

Earnings date

2026-11-13

Earnings time

amc

Employees

Employees change

-13

Employees growth

-40.63%

Enterprise value

$-118,221

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2017

Industry

Specialty Chemicals

Is primary listing

Yes

Is SPAC

ISIN number

US0906283066

Last 10-K release date

2026-04-14

Last earnings date

2026-08-14

Last refreshed

2026-10-28

Last stock split date

2025-04-07

Last stock split type

Reverse

Market cap

$3.1M

Market cap category

Nano-Cap

Next earnings date

2026-11-13

Options

Price

$1.05

Price currency

USD

Sector

Materials

SIC code

8071

Stock price date

2026-10-28

Symbol

BGLC

Website

https://www.bionexusgenelab.com

Metric	Value
Earnings yield	-113.17%
FCF / EV yield	1,433.37%
FCF yield	-27.2%
Industry forward P/E	19.58x
Industry P/E	43.86x
P/B ratio	0.35x
P/S ratio	1x
Price / tangible book value	0.4x
Sector forward P/E	15.1x
Sector P/E	22.71x

Metric

Value

Earnings yield

-113.17%

FCF / EV yield

1,433.37%

FCF yield

-27.2%

Industry forward P/E

19.58x

Industry P/E

43.86x

P/B ratio

0.35x

P/S ratio

Price / tangible book value

0.4x

Sector forward P/E

15.1x

Sector P/E

22.71x

Metric	Value
EBIT margin	-88.16%
EBITDA margin	-84.44%
Gross margin	12.34%
Operating margin	-88.16%
Pretax margin	-82.36%
Profit margin	-82.36%
Profit per employee	$-135,533
Revenue per employee	$164,557
ROA	-18.99%
ROA (5Y)	-8.84%
ROCE	-34.83%
ROE	-33.66%
ROE (5Y)	-15.9%
ROIC	-60.88%
ROIC (5Y)	-35.15%
SBC / revenue	25.42%

Metric

Value

EBIT margin

-88.16%

EBITDA margin

-84.44%

Gross margin

12.34%

Operating margin

-88.16%

Pretax margin

-82.36%

Profit margin

-82.36%

Profit per employee

$-135,533

Revenue per employee

$164,557

ROA

-18.99%

ROA (5Y)

-8.84%

ROCE

-34.83%

ROE

-33.66%

ROE (5Y)

-15.9%

ROIC

-60.88%

ROIC (5Y)

-35.15%

SBC / revenue

25.42%

Metric	Value
EPS growth quarters	2
EPS growth years	0
Gross profit growth	-71.36%
Gross profit growth (Q)	-96.47%
Gross profit growth 3Y	-34.08%
Gross profit growth 5Y	-27.72%
Net income growth quarters	2
Net income growth years	0
Revenue growth	-67.27%
Revenue growth (Q)	-96.63%
Revenue growth (QoQ)	233.4%
Revenue growth 3Y	-32.92%
Revenue growth 5Y	-25.65%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

-71.36%

Gross profit growth (Q)

-96.47%

Gross profit growth 3Y

-34.08%

Gross profit growth 5Y

-27.72%

Net income growth quarters

Net income growth years

Revenue growth

-67.27%

Revenue growth (Q)

-96.63%

Revenue growth (QoQ)

233.4%

Revenue growth 3Y

-32.92%

Revenue growth 5Y

-25.65%

Revenue growth years

Metric	Value
Capital expenditures	$-7,035
Depreciation and amortization	$116,512
EBIT	$-2.8M
EBITDA	$-2.6M
EPS	$-1.19
FCF per share	$-0.29
Financing cash flow	$374,047
Free cash flow	$-853,600
Free cash flow minus SBC	$-1.6M
Gross profit	$385,894
Investing cash flow	$1.4M
Net borrowing	$107,006
Net cash flow	$854,756
Net income	$-2.6M
Operating cash flow minus SBC	$-1.6M
Operating income	$-2.8M
Revenue	$3.1M
Stock-based compensation	$794,770

Metric

Value

Capital expenditures

$-7,035

Depreciation and amortization

$116,512

EBIT

$-2.8M

EBITDA

$-2.6M

EPS

$-1.19

FCF per share

$-0.29

Financing cash flow

$374,047

Free cash flow

$-853,600

Free cash flow minus SBC

$-1.6M

Gross profit

$385,894

Investing cash flow

$1.4M

Net borrowing

$107,006

Net cash flow

$854,756

Net income

$-2.6M

Operating cash flow minus SBC

$-1.6M

Operating income

$-2.8M

Revenue

$3.1M

Stock-based compensation

$794,770

Metric	Value
Altman Z-Score	3.65
Book value per share	$3.22
Debt / equity	0.04
Interest coverage	-163.17
Long-term assets	$3.8M
Long-term liabilities	$135,043
Net cash (debt)	$3.2M
Net cash / market cap	101.9%
Net cash growth	12.38%
Net debt / equity	-0.41
Piotroski F-Score	2
Property, plant and equipment	$1.8M
Shareholders' equity	$7.8M
Tangible book value	$7.8M
Tangible book value per share	$3.22
Total assets	$8.7M
Total cash	$3.5M
Total debt	$323,197
Total liabilities	$947,981
WACC	15.2%

Metric

Value

Altman Z-Score

3.65

Book value per share

$3.22

Debt / equity

0.04

Interest coverage

-163.17

Long-term assets

$3.8M

Long-term liabilities

$135,043

Net cash (debt)

$3.2M

Net cash / market cap

101.9%

Net cash growth

12.38%

Net debt / equity

-0.41

Piotroski F-Score

Property, plant and equipment

$1.8M

Shareholders' equity

$7.8M

Tangible book value

$7.8M

Tangible book value per share

$3.22

Total assets

$8.7M

Total cash

$3.5M

Total debt

$323,197

Total liabilities

$947,981

WACC

15.2%

Metric	Value
Asset turnover	0.34
Current assets	$4.9M
Current liabilities	$812,938
Current ratio	6.08
Inventory turnover	2.93
Net working capital	$797,093
Quick ratio	4.56
Working capital	$4.1M
Working capital turnover	0.71

Metric

Value

Asset turnover

0.34

Current assets

$4.9M

Current liabilities

$812,938

Current ratio

6.08

Inventory turnover

2.93

Net working capital

$797,093

Quick ratio

4.56

Working capital

$4.1M

Working capital turnover

0.71

Metric	Value
Buyback yield / dilution	-20.61%
Dividend yield	0%
Shareholder yield	-20.61%

Metric

Value

Buyback yield / dilution

-20.61%

Dividend yield

Shareholder yield

-20.61%

Metric	Value
150-day SMA	$1.81
1D price change	-7.08%
1M price change	-23.74%
1M total return	-23.74%
1W price change	-12.03%
1W total return	-12.03%
1Y price change	-79.05%
1Y return CAGR	-79.07%
1Y total return	-79.05%
20-day SMA	$1.23
200-day SMA	$2.02
3M price change	-22.63%
3M total return	-22.63%
3Y price change	-73.97%
3Y return CAGR	-36.14%
3Y total return	-73.97%
50-day SMA	$1.38
50-day SMA vs 200-day SMA	50under200
52-week high	$5.67
52-week high date	2025-11-03
52-week low	$1.04
52-week low date	2026-10-28
5Y price change	-99.55%
5Y return CAGR	-66.03%
5Y total return	-99.55%
6M price change	-51.15%
6M total return	-51.15%
All-time high	$414.00
All-time high date	2020-10-21
All-time low	$1.05
All-time low date	2026-10-28
Average true range (ATR)	$0.07
Average volume	7.5K
Beta (1Y)	1.57
Beta (2Y)	1.25
Beta (5Y)	2.2
Change from 52-week high	-81.48%
Change from 52-week low	0.96%
Change from all-time high	-99.74%
Change from all-time low	1.22%
Change from open	0%
Day's gap	-7.08%
Dollar volume	$4,115
High price	$1.05
Low price	$1.05
Monthly RSI	32.71
Open price	$1.05
Premarket change	-1.77%
Premarket close	$1.13
Premarket price	$1.11
Previous close	$1.13
Price vs 150-day SMA	-41.31%
Price vs 20-day SMA	-13.89%
Price vs 200-day SMA	-47.55%
Price vs 50-day SMA	-23.08%
Relative volume	0.52
RSI	31.14
Sharpe ratio	-2.1
Sharpe ratio (3Y)	0.48
Sortino ratio	-2.65
Sortino ratio (3Y)	1.76
Volume	3.9K
Weekly RSI	28.31
YTD price change	-73.16%
YTD total return	-73.16%

Metric

Value

150-day SMA

$1.81

1D price change

-7.08%

1M price change

-23.74%

1M total return

-23.74%

1W price change

-12.03%

1W total return

-12.03%

1Y price change

-79.05%

1Y return CAGR

-79.07%

1Y total return

-79.05%

20-day SMA

$1.23

200-day SMA

$2.02

3M price change

-22.63%

3M total return

-22.63%

3Y price change

-73.97%

3Y return CAGR

-36.14%

3Y total return

-73.97%

50-day SMA

$1.38

50-day SMA vs 200-day SMA

50under200

52-week high

$5.67

52-week high date

2025-11-03

52-week low

$1.04

52-week low date

2026-10-28

5Y price change

-99.55%

5Y return CAGR

-66.03%

5Y total return

-99.55%

6M price change

-51.15%

6M total return

-51.15%

All-time high

$414.00

All-time high date

2020-10-21

All-time low

$1.05

All-time low date

2026-10-28

Average true range (ATR)

$0.07

Average volume

7.5K

Beta (1Y)

1.57

Beta (2Y)

1.25

Beta (5Y)

2.2

Change from 52-week high

-81.48%

Change from 52-week low

0.96%

Change from all-time high

-99.74%

Change from all-time low

1.22%

Change from open

Day's gap

-7.08%

Dollar volume

$4,115

High price

$1.05

Low price

$1.05

Monthly RSI

32.71

Open price

$1.05

Premarket change

-1.77%

Premarket close

$1.13

Premarket price

$1.11

Previous close

$1.13

Price vs 150-day SMA

-41.31%

Price vs 20-day SMA

-13.89%

Price vs 200-day SMA

-47.55%

Price vs 50-day SMA

-23.08%

Relative volume

0.52

RSI

31.14

Sharpe ratio

-2.1

Sharpe ratio (3Y)

0.48

Sortino ratio

-2.65

Sortino ratio (3Y)

1.76

Volume

3.9K

Weekly RSI

28.31

YTD price change

-73.16%

YTD total return

-73.16%

Metric	Value
Float	1.7M
Float percentage	56.96%
Shares change (QoQ)	0%
Shares change (YoY)	20.61%
Shares held by insiders	29.66%
Shares held by institutions	6.46%
Shares outstanding	2.9M
Short % of float	0.61%
Short % of shares	0.34%
Short ratio	2 days

Metric

Value

Float

1.7M

Float percentage

56.96%

Shares change (QoQ)

Shares change (YoY)

20.61%

Shares held by insiders

29.66%

Shares held by institutions

6.46%

Shares outstanding

2.9M

Short % of float

0.61%

Short % of shares

0.34%

Short ratio

2 days

BioNexus Gene Lab Corp. (BGLC)

Price

Financial snapshot

Fair-value bridge

Latest news · BGLC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BGLC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BGLC

Frequently asked questions